Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Are the Key Projections for the CAGR of the Anaphylaxis Market Size From 2025 to 2034?

The market size of anaphylaxis has recorded a significant increase in the past few years. Its value is projected to rise from $3.24 billion in 2024 to $3.51 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. The past growth has been influenced by factors such as the increasing incidence of food allergies, heightened awareness of anaphylaxis, enhancement in healthcare infrastructure, improved diagnostic procedures and management, and the growing presence of epinephrine auto-injectors.

In the succeeding years, a robust expansion is forecasted for the anaphylaxis market, with projections reaching $4.81 billion in 2029, boasting a compound annual growth rate (CAGR) of 8.2%. The surge anticipated during the forecast period is influenced by factors such as enhanced urbanization and lifestyle adjustments, escalating incidences of anaphylaxis, swelling disposable earnings in burgeoning markets, government support for allergy research, and advancements in emergency treatment delivery systems. Key trends in the projected period include surging requests for auto-injector injections, the integration of digital health solutions into anaphylaxis care, a heightened emphasis on product affordability, growth in preventative remedies and vaccinations, and the escalated application of biologics for treating allergies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

What Are the Core Growth Drivers Propelling the Anaphylaxis Market Forward?

The growth of the anaphylaxis market is anticipated to be fueled by the increasing incidence of food allergies. Food allergies are reactions of the immune system provoked by specific foods, leading to a range of symptoms that can vary from mild to severe, including life-threatening anaphylaxis. The upsurge in food allergy incidents can be attributed to factors such as changes in eating habits, environmental influences, and heightened awareness and diagnostic precision. The intervention provided by anaphylaxis treatment is crucial for food allergy sufferers as it immediately reverses severe allergic reactions, mitigating symptoms like swelling, respiratory difficulty, and decreased blood pressure, thereby ensuring immediate stabilization. Furthermore, it aids in averting potentially fatal outcomes by equipping patients with the necessary tools to promptly react to future allergic episodes. The World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, noted in September 2024 that approximately 220 million individuals worldwide are affected by food allergies. A single food item can contain various allergens, and a person can be allergic to multiple foods. Moreover, the Patterns and Prevalence of Adult Food Allergy (PAFA) report released by the Food Standards Agency (FSA), a non-ministerial department based in the UK, showed in May 2024 that over 30% of adults experienced adverse reactions to food. Clinical evaluations affirmed food allergies in roughly 6% of UK adults, approximating to about 2.4 million individuals. As a result, the anaphylaxis market is experiencing growth due to the escalating incidence of food allergies.

What Segment Types Define the Anaphylaxis Market Structure?

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Beta-antagonists, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Beta-antagonists: Selective Beta-blockers, Non-selective Beta-blockers

5) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21096&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2024. The regions covered in the anaphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theAnaphylaxis Industry Evolution?

Key players in the anaphylaxis market are shifting their focus towards the creation of advanced epinephrine nasal sprays, aiming to provide faster and more effective medication delivery in emergency situations. This nasal spray is a medical device designed to administer epinephrine, also known as adrenaline, through the nostrils to treat severe allergic reactions, including anaphylaxis. For example, in August 2024, ARS Pharmaceuticals, a biotechnology firm based in the US, received approval from the Food and Drug Administration, a government agency in the US, for their product Neffy (an epinephrine nasal spray). This marked the product as the first and only non-needle treatment for type I allergic reactions, including anaphylaxis. This groundbreaking nasal spray promises a less threatening alternative to traditional epinephrine autoinjectors, potentially making emergency treatment more accessible. Neffy is designed to increase patient consent by removing the need for needles and providing quick, potentially life-saving epinephrine during severe allergic attacks.

View the full report here:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

What Is the Definition of the Anaphylaxis Market?

Anaphylaxis is a severe, life-threatening allergic reaction that occurs rapidly, often resulting in difficulty breathing, swelling, and a drop in blood pressure, requiring immediate medical intervention. Management of anaphylaxis involves prompt administration of epinephrine, followed by monitoring in a healthcare setting to stabilize the patient and prevent further complications.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21096

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model